
Transactions: Healthcare
Filter


Private placement of equity in A+ Science Investment AB (SE) — SEK 71 million

Private placement of equity in Boule Diagnostics (SE) — SEK 44 million

Secondary placing of 965,000 shares in Meda AB (SE) — SEK 300 million

Divestment of AB Previa (SE) to Tryg i Danmark smba (DK) by Segulah (SE) — Amount not disclosed.

Rights issue in Oasmia Pharmaceutical (SE) — SEK 239 million

Divestment of Investor’s 14 per cent stake in Global Health Partner AB (SE)


Public bid and acquisition by Baxter Inc (US) of Althin Medical (SE) — SEK 1.1 billion
Initial public offering of Bavarian Nordic Research Institute A/S (DK) — DKK 195 million


Merger of Axis Biochemicals ASA (NO) and Shield Diagnostics (UK) — NOK 970 million


Divestment of SBL Vaccin (SE) by the Swedish Government (SE) — SEK 345 million


Divestment and equity financing of Biovitrum AB (SE) — SEK 1.6 billion
- Föregående
- 1
- …
- 26
- 27
- 28
- Nästa